Smith & Nephew plc

SNN NYSE Healthcare & Biotech Monde US83175M2052
31.32 $
3.23 %

Smith & Nephew is a company that develops and markets advanced medical devices used primarily in orthopedics, trauma, and surgery.

Price history of Smith & Nephew plc
Price history of Smith & Nephew plc

Performance & Momentum

6 Months 6.17 %
1 Year 4.54 %
3 Years 10.70 %
5 Years 19.51 %

Strategic Analysis

Smith & Nephew plc • 2026

Smith & Nephew is a global medical technology player positioned around three complementary pillars: orthopaedics, sports medicine and wound care. Its strategic appeal lies in a diversified portfolio of devices with strong clinical expertise, exposed to recurring medical needs structurally supported by population ageing and the increase in orthopaedic procedures.

Strengths
  • Global presence in specialized medical segments, with barriers to entry linked to regulatory and clinical expertise
  • Diversification across orthopaedics, sports medicine and wound care, which reduces reliance on a single product line
  • Exposure to defensive and recurring markets, supported by long-term healthcare needs
Weaknesses
  • Patchy share-price history, reflecting still inconsistent value creation for shareholders
  • Sensitivity to competition and pricing pressure in medical devices, especially in mature product lines
Momentum

Momentum appears moderately constructive, without being particularly strong. The recent trend suggests an improvement compared with weaker periods, but the path remains uneven and does not yet confirm a lasting return in confidence. For investors, this points to a sector quality name worth monitoring, but one that still needs evidence of renewed operational and market momentum.

Similar stocks to Smith & Nephew plc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone